GAITHERSBURG, Md., January 26, 2021 — GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias. With these additions, GeneDx has created a comprehensive and affordable offering that covers the […]
Tag Archives: genedx
GAITHERSBURG, Md., August 12, 2020 – GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical subspecialty physician services, to offer state-of-the-art, […]
GenomeXpress is a rapid genome sequencing test, reporting results within approximately seven days GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ — GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress results of pathogenic and/or likely pathogenic variants in known disease causing genes are […]
GeneDx’s Gaithersburg and BioReference’s Melbourne facilities offer COVID-19 testing ELMWOOD PARK, N.J., April 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced its subsidiary GeneDx will begin testing for COVID-19 to further expand public access to testing. In addition, BioReference will leverage its Melbourne, Florida facility to increase COVID-19 testing capacity, […]
We’re celebrating something BIG today – our specialty genetics laboratory, GeneDx, turns 20! If you haven’t heard of GeneDx, they are a global leader and pioneer in advanced genetic and genomics testing, and specialize in diagnosing rare and ultra-rare disorders. With over 300 million people in the world living with a rare disease, GeneDx’s 20 […]
Elmwood Park, NJ, Nov. 04, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, and women’s health division, GenPath, today announced the presentation of new research from its genetics program at the National Society for Genetic Counselors (NSGC) 38th Annual Conference in Salt Lake City, […]